Related Experiment Video
Updated: Apr 5, 2026

08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
13.6K
The Vulnerable Ventral Tegmental Area in Parkinson's Disease
Stephanie L Alberico1, Martin D Cassell2, Nandakumar S Narayanan1
1Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States.
Basal Ganglia
|August 8, 2015
Summary
Parkinson's disease (PD) involves the degeneration of dopaminergic neurons in the ventral tegmental area (VTA), though less than in the substantia nigra. This study confirms VTA involvement in PD neuropathology.
Area of Science:
- Neuroscience
- Neuropathology
Background:
- Dopaminergic neuron loss in Parkinson's disease (PD) is primarily associated with the substantia nigra pars compacta (SNpc).
- The role of the ventral tegmental area (VTA) in PD pathogenesis remains under-recognized.
- This study reviews existing literature and presents new post-mortem evidence on VTA involvement in PD.
Purpose of the Study:
- To investigate and confirm the degeneration of dopaminergic neurons in the VTA in Parkinson's disease.
- To compare the extent of VTA degeneration with SNpc degeneration in PD.
Main Methods:
- A comprehensive literature review of neuropathological studies on PD.
- Analysis of three new post-mortem Parkinson's disease cases.
- Sectioning and tyrosine hydroxylase staining of brain tissue from PD and control cases.
- Quantification of dopaminergic neurons in the SNpc and VTA.
Main Results:
- The ventral tegmental area (VTA) demonstrably degenerates in Parkinson's disease.
- Degeneration in the VTA is less severe compared to the substantia nigra pars compacta (SNpc) in PD cases.
Conclusions:
- The VTA is unequivocally involved in the neuropathology of Parkinson's disease.
- While clinical data interpretation is limited, VTA involvement may be crucial for understanding non-motor symptoms in PD.
- Further research into the VTA's role in PD is warranted.
Related Concept Videos
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Neural Regulation
44.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.9K

